Healthcare Global Enterprises Q3 Results Review
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Healthcare Global Enterprises Ltd. reported revenue of Rs 425 crore, up 18.6% YoY, which was above our expectations. The said growth was primarily driven by healthy average revenue per occupied bed (Rs 37,000) which reported a de-growth of 3.5% YoY. The number of occupied bed days grew by 30% YoY.
Healthcare Global’s Ebitda margins improved by 50 basis points YoY due to high operating leverage as existing centers reported healthy Ebitda margins of 25.4% and new centers reported the highest-ever Ebitda margins of 7.7% in Q3 FY23.
However, over the last four quarters, consolidated the company’s Ebitda margins have been flat (range 18.2%) despite a fall in other expenses as expenses have been increasing in the Medical Consultancy segment.
Reported profit after tax after adjustment is Rs 4.7 crore versus a loss of Rs 2.0 crore YoY for Q3 FY23.
Click on the attachment to read the full report:
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.